← FDA Drug Approvals (Drugs@FDA)

ZIMRIXBY

BLA · Biologics License Application · Sponsor: DR REDDYS LABS SA · Approved 2026-07-31

Drug application

FDA Application #

BLA761376

Application type

Biologics License Application

Brand name

ZIMRIXBY

Generic name

Rituximab-Cdxx

Active ingredients

RITUXIMAB-CDXX

Dosage form

INJECTION

Route

—

Marketing status

Prescription

Sponsor

DR REDDYS LABS SA

First approval

2026-07-31

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown